Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: If only I'd held who wrote (78919)	6/10/1999 1:56:00 PM
From: reikjavic	Respond to of 119973

check this out> KNSY float 3.5mln > lady called it on cheetah for news>have'nt found news yet but up 15/16 Kensey Nash is a medical device company established in three technology platforms; puncture closure (Angio-Seal), biomaterials (collagen and resorbable polymers) and revasculariztion (Aegis Vortex System). For the six months ended 12/98, revenues rose 68% to $7.3 million. Net income totalled $1 million vs. a loss of $679 thousand. Revenues reflect increased U.S. and European demand for Angio-Seal. Earnings also reflect favorable trends in gross margins. Valuation Ratios Price/Book (mrq) 3.95 Price/Earnings (ttm) 30.20 Price/Sales (ttm) 4.39 52-Week Low $4.688 Recent Price $8.938 52-Week High $18.625 Beta 0.36 Daily Volume (3-month avg) 20.0K Shares Short as of May 10, 1999 40.0K Short Ratio 1.74